Ramucirumab Plus Paclitaxel: A Possible New Chemotherapy Regimen for Neuroendocrine Carcinoma of the Stomach

Intern Med. 2018 Mar 1;57(5):631-632. doi: 10.2169/internalmedicine.9709-17. Epub 2017 Nov 20.
No abstract available

Keywords: chemotherapy; neuroendocrine carcinoma; paclitaxel; ramucirumab; stomach; vascular endothelial growth factor receptor.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Neuroendocrine
  • Humans
  • Paclitaxel*
  • Ramucirumab
  • Stomach Neoplasms

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Paclitaxel